Actively Recruiting
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Led by Lo.Li.Pharma s.r.l · Updated on 2026-02-12
60
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or product.
CONDITIONS
Official Title
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 30 to 40 years
- Uterine fibroid with diameter greater than or equal to 4 cm or multiple fibroids
- Eligible for surgery
- Symptoms such as heavy menstrual bleeding (menometrorrhagia) or pelvic pain
You will not qualify if you...
- Body mass index (BMI) over 30
- Currently pregnant or breastfeeding
- Diabetes diagnosis
- Suspected malignancy
- Diagnosis of cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ospedale Dario camberlingo
Francavilla Fontana, Apulia, Italy, 72021
Actively Recruiting
2
Ospedale Veris Delli Ponti
Scorrano, Apulia, Italy, 73020
Not Yet Recruiting
Research Team
M
Massimo Stomati, Ph. D
CONTACT
A
Andrea Tinelli, Ph. D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here